Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
Intravenous (IV) iron and Erythropoiesis Stimulating Agents (ESAs) are recommended for anemia management in chronic kidney disease (CKD). This retrospective cohort study analyzed utilization patterns of IV iron and ESA in patients over 18 years of age admitted to University Health System Hospitals w...
Saved in:
Main Authors: | Avani D. Joshi, David A. Holdford, Donald F. Brophy, Spencer E. Harpe, Darcy Mays, Todd W. B. Gehr |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Anemia |
Online Access: | http://dx.doi.org/10.1155/2012/248430 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Appropriate Use of Inpatient Erythropoiesis Stimulating Agents
by: Chenghao Cui, et al.
Published: (2024-11-01) -
Effect of iron fortification and prebiotics on iron biomarkers in anemic rats
by: S. Iqbal, et al.
Published: (2025-01-01) -
Crosstalk between Erythropoiesis and Iron Metabolism
by: Stefano Rivella, et al.
Published: (2010-01-01) -
Comparison of Birth Weights of Pre-Delivery Anemic and Non-Anemic Routine Iron Supplemented Pregnant Women
by: Tolga Atakul
Published: (2020-03-01) -
Iron Loading and Overloading due to Ineffective Erythropoiesis
by: Toshihiko Tanno, et al.
Published: (2010-01-01)